Chargement en cours...
The Case for Proteomics and Phospho‐Proteomics in Personalized Cancer Medicine
The concept of personalized medicine is predominantly been pursued through genomic and transcriptomic technologies, leading to the identification of multiple mutations in a large variety of cancers. However, it has proven challenging to distinguish driver and passenger mutations and to deal with tum...
Enregistré dans:
| Publié dans: | Proteomics Clin Appl |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6519247/ https://ncbi.nlm.nih.gov/pubmed/30790462 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prca.201800113 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|